Skip to Main Content

Author Details

Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
2002
25
12
PMIDPaper TitleJournal TitlePublished Year
36470093Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.Eur J Cancer2023
37884744NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.NPJ Precis Oncol2023
37734378Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.Cell Rep Med2023
36888935National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.JCO Clin Cancer Inform2023
35101336Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
36063163Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
32949162Integrating proteomics into precision oncology.Int J Cancer2021
34808524Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.ESMO Open2021
34690926Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.Front Endocrinol (Lausanne)2021
34036222CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.JCO Precis Oncol2021
34112699Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.Cancer Discov2021
33222322Analysis of mutational signatures with yet another package for signature analysis.Genes Chromosomes Cancer2021
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
31558800Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains.Oncogene2020
32843432Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinoma.Cold Spring Harb Mol Case Stud2020
32501622Germline SDHB-inactivating mutation in gastric spindle cell sarcoma.Genes Chromosomes Cancer2020
32385320The landscape of chromothripsis across adult cancer types.Nat Commun2020
31008532Variant classification in precision oncology.Int J Cancer2019
31798980Community-driven development of a modified progression-free survival ratio for precision oncology.ESMO Open2019
30833416Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistance.Cold Spring Harb Mol Case Stud2019
35135162Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.JCO Precis Oncol2018
12021493Developmental potential of hematopoietic and neural stem cells: unique or all the same?Cells Tissues Organs2002
  • 1 - 25 of 25

Recommended Authors

Melika Bonakdar
Career Start Year 2017
Number of shared co-authors 7
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 0
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Career Start Year 2016
Number of shared co-authors 2
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 15
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 16
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 13
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 3
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 2
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 15
Joshua F McMichael
Washington University
Career Start Year 2009
Number of shared co-authors 17
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 17
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 17
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 2
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 22
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 3
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 10
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 18
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 4
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 3
Paul T Fanta
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 0

Collaborators

Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 20
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 20
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 18
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 16
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 14
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 14
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Co-authored papers 10
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 5
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Co-authored papers 4
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 4
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Damian T Rieke
German Cancer Consortium and German Cancer Research Center
Co-authored papers 3
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 3
Stephan Wolf
Co-authored papers 3
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 3
Marc Zapatka
Co-authored papers 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Malachi Griffith
Washington University
Co-authored papers 2
Arpad M Danos
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 2
Harry Lesmana
Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute
Co-authored papers 2
Obi L Griffith
Washington University
Co-authored papers 2
Xinjie Xu
Mayo Clinic
Co-authored papers 2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Matthias Schlesner
University of Augsburg
Co-authored papers 2
Beth A Pitel
Mayo Clinic
Co-authored papers 2
Lisa Barrow-Laing
Indiana University School of Medicine
Co-authored papers 2
Lars Feuerbach
German Cancer Research Center (DKFZ)
Co-authored papers 2
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 2
Release 1.2